JP2012092103A5 - - Google Patents

Download PDF

Info

Publication number
JP2012092103A5
JP2012092103A5 JP2011237399A JP2011237399A JP2012092103A5 JP 2012092103 A5 JP2012092103 A5 JP 2012092103A5 JP 2011237399 A JP2011237399 A JP 2011237399A JP 2011237399 A JP2011237399 A JP 2011237399A JP 2012092103 A5 JP2012092103 A5 JP 2012092103A5
Authority
JP
Japan
Prior art keywords
alkyl
fluoro
chloro
bromo
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011237399A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012092103A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2012092103A publication Critical patent/JP2012092103A/ja
Publication of JP2012092103A5 publication Critical patent/JP2012092103A5/ja
Pending legal-status Critical Current

Links

JP2011237399A 2004-12-09 2011-10-28 エストロゲン受容体モジュレーター Pending JP2012092103A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63478504P 2004-12-09 2004-12-09
US60/634,785 2004-12-09

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2007545542A Division JP2008523065A (ja) 2004-12-09 2005-12-05 エストロゲン受容体モジュレーター

Publications (2)

Publication Number Publication Date
JP2012092103A JP2012092103A (ja) 2012-05-17
JP2012092103A5 true JP2012092103A5 (enExample) 2013-01-17

Family

ID=36578441

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007545542A Withdrawn JP2008523065A (ja) 2004-12-09 2005-12-05 エストロゲン受容体モジュレーター
JP2011237399A Pending JP2012092103A (ja) 2004-12-09 2011-10-28 エストロゲン受容体モジュレーター

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2007545542A Withdrawn JP2008523065A (ja) 2004-12-09 2005-12-05 エストロゲン受容体モジュレーター

Country Status (15)

Country Link
US (1) US7511152B2 (enExample)
EP (1) EP1827421B1 (enExample)
JP (2) JP2008523065A (enExample)
KR (1) KR20070085874A (enExample)
CN (1) CN101087606B (enExample)
AU (1) AU2005314230B2 (enExample)
BR (1) BRPI0518874A2 (enExample)
CA (1) CA2590860C (enExample)
IL (1) IL183543A (enExample)
MX (1) MX2007006878A (enExample)
NO (1) NO20073511L (enExample)
NZ (1) NZ555316A (enExample)
RU (1) RU2394820C2 (enExample)
WO (1) WO2006062876A2 (enExample)
ZA (1) ZA200704223B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006065599A1 (en) * 2004-12-17 2006-06-22 Bionovo, Inc. Method of using extracts of epimedium species
US7482029B2 (en) * 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
EP1943224B1 (en) * 2005-10-05 2011-07-27 Merck Sharp & Dohme Corp. Estrogen receptor modulators
US7700136B2 (en) * 2005-11-14 2010-04-20 Bionovo, Inc. Scutellaria barbata extract for the treatment of cancer
US9604931B2 (en) 2007-01-22 2017-03-28 Gtx, Inc. Nuclear receptor binding agents
KR101638035B1 (ko) 2007-01-22 2016-07-11 지티엑스, 인코포레이티드 핵 수용체에 결합하는 물질
US9623021B2 (en) 2007-01-22 2017-04-18 Gtx, Inc. Nuclear receptor binding agents
US20090042818A1 (en) * 2007-06-22 2009-02-12 Bionovo, Inc. Liquiritigenin and Derivatives as Selective Estrogen Receptor Beta Agonists
US20080319051A1 (en) * 2007-06-22 2008-12-25 Bionovo, Inc. Liquiritigenin and derivatives as selective estrogen receptor beta agonists
AU2008285325A1 (en) * 2007-08-08 2009-02-12 Bionovo, Inc. Extracts of Ligustrum lucidum and uses thereof
AU2008296076A1 (en) * 2007-09-07 2009-03-12 Bionovo, Inc. Estrogenic extracts of Pueraria lobata Willd, Ohwi of the Leguminosae family and uses thereof
US20090068298A1 (en) * 2007-09-07 2009-03-12 Bionovo, Inc. ESTROGENIC EXTRACTS OF Astragalus membranaceus Fisch. Bge. Var. mongolicus Bge. of the Leguminosae Family AND USES THEREOF
AU2008296136A1 (en) * 2007-09-07 2009-03-12 Bionovo. Inc. Estrogenic extracts of Scuttelaria barbata D. Don of the Labiatae Family and uses thereof
WO2009033025A1 (en) * 2007-09-07 2009-03-12 Bionovo, Inc. Estrogenic extracts of asparagus conchinchinensis (lour.) merr of the liliaceae family and uses thereof
US8512961B2 (en) 2007-11-19 2013-08-20 Bionovo, Inc. Methods of detecting and treatment of cancers using Scutellaria barbata extract
US20090130101A1 (en) * 2007-11-19 2009-05-21 Bionovo, Inc. Anti-cancer therapy with an extract of scutellaria barbata
AU2008326431A1 (en) * 2007-11-19 2009-05-28 Bionovo, Inc. Scutellaria barbata extract and combinations for the treatment of cancer
WO2009070478A2 (en) * 2007-11-19 2009-06-04 Bionovo, Inc. A process of making purified extract of scutellaria barbata d. don
AU2009236339A1 (en) * 2008-04-14 2009-10-22 Bionovo, Inc. Calycosin and analogs thereof for the treatment of estrogen receptor beta-mediated diseases
JP2011519947A (ja) * 2008-05-06 2011-07-14 バイオノボ・インコーポレーテッド 膣および外陰の委縮を治療するために使用するエストロゲン様抽出物
US20090311349A1 (en) * 2008-06-05 2009-12-17 Bionovo, Inc., A Delaware Corporation Method of quantification of multiple bioactives from botanical compositions
US20090312437A1 (en) * 2008-06-06 2009-12-17 Bionovo, Inc., A Delaware Corporation Anthraquinones and Analogs from Rhuem palmatum for Treatment of Estrogen Receptor Beta-Mediated Conditions
US20100069480A1 (en) * 2008-09-03 2010-03-18 Bionovo, Inc. A Delaware Corporation Methods and compositions for the treatment of cancer
WO2010129343A2 (en) * 2009-04-28 2010-11-11 Bionovo, Inc. Method of reducing fat accumulation and inducing weight loss
CN105960236A (zh) 2013-12-05 2016-09-21 卡罗医药股份公司 用于治疗间皮瘤的雌激素受体β激动剂
WO2017107754A1 (zh) * 2015-12-22 2017-06-29 江苏恒瑞医药股份有限公司 苯并哌啶类衍生物、其制备方法及其在医药上的应用

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4294926A (en) 1979-06-15 1981-10-13 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
US4319039A (en) 1979-06-15 1982-03-09 Merck & Co., Inc. Preparation of ammonium salt of hypocholesteremic fermentation product
US4231938A (en) 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
US4444784A (en) 1980-08-05 1984-04-24 Merck & Co., Inc. Antihypercholesterolemic compounds
MX7065E (es) 1980-06-06 1987-04-10 Sankyo Co Un procedimiento microbiologico para preparar derivados de ml-236b
JPS5889191A (ja) 1981-11-20 1983-05-27 Sankyo Co Ltd 3−ヒドロキシ−ml−236b誘導体の製造法
HU204253B (en) 1982-11-22 1991-12-30 Sandoz Ag Process for producing mevalonolactone analogues and derivatives and pharmaceutical compositions containing them
US5354772A (en) 1982-11-22 1994-10-11 Sandoz Pharm. Corp. Indole analogs of mevalonolactone and derivatives thereof
US4911165A (en) 1983-01-12 1990-03-27 Ethicon, Inc. Pliabilized polypropylene surgical filaments
US4681893A (en) 1986-05-30 1987-07-21 Warner-Lambert Company Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
US4782084A (en) 1987-06-29 1988-11-01 Merck & Co., Inc. HMG-COA reductase inhibitors
US4885314A (en) 1987-06-29 1989-12-05 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
US4820850A (en) 1987-07-10 1989-04-11 Merck & Co., Inc. Process for α-C-alkylation of the 8-acyl group on mevinolin and analogs thereof
US5180589A (en) 1988-03-31 1993-01-19 E. R. Squibb & Sons, Inc. Pravastatin pharmaceuatical compositions having good stability
US5030447A (en) 1988-03-31 1991-07-09 E. R. Squibb & Sons, Inc. Pharmaceutical compositions having good stability
US4916239A (en) 1988-07-19 1990-04-10 Merck & Co., Inc. Process for the lactonization of mevinic acids and analogs thereof
US5118853A (en) 1988-10-13 1992-06-02 Sandoz Ltd. Processes for the synthesis of 3-disubstituted aminoacroleins
US5290946A (en) 1988-10-13 1994-03-01 Sandoz Ltd. Processes for the synthesis of 3-(substituted indolyl-2-yl)propenaldehydes
US4929437A (en) 1989-02-02 1990-05-29 Merck & Co., Inc. Coenzyme Q10 with HMG-CoA reductase inhibitors
US5189164A (en) 1989-05-22 1993-02-23 Sandoz Ltd. Processes for the synthesis of syn-(E)-3,5-dihydroxy-7-substituted hept-6-enoic and heptanoic acids and derivatives and intermediates thereof
FI94339C (fi) 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
US5177080A (en) 1990-12-14 1993-01-05 Bayer Aktiengesellschaft Substituted pyridyl-dihydroxy-heptenoic acid and its salts
HU9203780D0 (en) 1991-12-12 1993-03-29 Sandoz Ag Stabilized pharmaceutical products of hmg-coa reductase inhibitor and method for producing them
US5298627A (en) 1993-03-03 1994-03-29 Warner-Lambert Company Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis
DE19523446A1 (de) * 1995-06-28 1997-01-02 Bayer Ag Benzotriazole
EA200100972A1 (ru) 1999-03-15 2002-02-28 Аксис Фармасьютикалз, Инк. Новые соединения и композиции как ингибиторы протеаз
DE60132975T2 (de) 2000-01-06 2009-02-26 Merck Frosst Canada Inc., Kirkland Neue substanzen und verbindungen als protease-inhibitoren
JP4331913B2 (ja) * 2000-02-14 2009-09-16 メルク エンド カムパニー インコーポレーテッド エストロゲンレセプターモデュレーター
GB0012209D0 (en) 2000-05-19 2000-07-12 Novartis Ag Organic compounds
DK1296689T3 (da) * 2000-06-20 2005-11-28 Novartis Ag Fremgangsmåde til indgivelse af bisphosphonater
JP4119246B2 (ja) * 2000-11-27 2008-07-16 メルク エンド カムパニー インコーポレーテッド エストロゲンレセプター修飾物質
JP2005502654A (ja) * 2001-08-13 2005-01-27 メルク エンド カムパニー インコーポレーテッド 選択的エストロゲン受容体調節剤
CA2497934A1 (en) 2002-09-19 2004-04-01 Merck & Co., Inc. Tryptophan hydroxylase assay
AR051597A1 (es) * 2004-11-01 2007-01-24 Merck & Co Inc Moduladores de los receptores de estrogeno

Similar Documents

Publication Publication Date Title
JP2016503793A5 (enExample)
JP2011105738A5 (enExample)
JP2010536766A5 (enExample)
JP2009535462A5 (enExample)
JP2010501534A5 (enExample)
JP2010504286A5 (enExample)
JP2013537203A5 (enExample)
JP2013521295A5 (enExample)
JP2016503797A5 (enExample)
JP2013532130A5 (enExample)
JP2013032389A5 (enExample)
JP2013532687A5 (enExample)
JP2014526533A5 (enExample)
JP2014508753A5 (enExample)
JP2016540742A5 (enExample)
JP2011518833A5 (enExample)
JP2010095546A5 (enExample)
JP2014500861A5 (enExample)
JP2014506907A5 (enExample)
JP2015516427A5 (enExample)
JP2015199738A5 (enExample)
JP2015512883A5 (enExample)
JP2011513410A5 (enExample)
JP2015535847A5 (enExample)
JP2014513051A5 (enExample)